Manufacturer and supplier iX Biopharma insists finances are secure despite auditor concerns by Steve Jones October 9, 2024October 10, 2024 Medicinal cannabis manufacturer iX Biopharma has insisted it can and will continue to operate as a […]
Cann Group goes back to investors in bid to raise $6.25m for product expansion by Steve Jones October 8, 2024October 8, 2024
CanView and tech provider C4C in deadlock as court-ordered mediation fails by Steve Jones October 3, 2024October 3, 2024
The ‘new’ compounding rules are just plain common sense by Dr Teresa Nicoletti October 3, 2024October 3, 2024
Financial support for cultivator ‘shows potential of medicinal cannabis’ by Steve Jones October 2, 2024October 3, 2024
NSW SAS-B approvals below annual average following crackdown by Steve Jones October 2, 2024October 2, 2024
Montu share buy-back offer on ice as shareholders report plan to Takeovers Panel and demand independent report by Steve Jones September 26, 2024October 25, 2024
A revolving door of senior staff: what’s behind the turbulence at Cannatrek? by Steve Jones September 26, 2024September 26, 2024
Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’ by Steve Jones September 26, 2024September 26, 2024
New compounding guidelines signal ‘willingness of regulator to enforce the rules’, pharmacists are warned by Steve Jones September 26, 2024September 26, 2024
